9 Things to Know About HRT and Migraines in Perimenopause
The migraine question stopped me in my tracks when I was first considering HRT. Nobody warned me that the answer wasn't simply yes or no — it was 'it depends,' and learning what it depends on genuinely changed everything. If migraines are the reason you're hesitating about hormone therapy, this one is worth reading slowly.
Learn more about Rose →Fluctuating oestrogen — not just low oestrogen — is the primary migraine trigger in perimenopause
Migraines are exquisitely sensitive to oestrogen withdrawal and rapid fluctuation, not simply to low levels. During perimenopause, oestrogen swings unpredictably from high to low within the same cycle, and it is those drops that most commonly trigger attacks. This is why migraines often worsen in perimenopause even before periods become irregular — the hormonal volatility starts years earlier.
Transdermal oestrogen is significantly less likely to trigger migraines than oral HRT
Oral oestrogen undergoes first-pass liver metabolism, which creates more variable blood levels and can provoke the sharp dips that trigger migraines. Transdermal patches, gels, and sprays deliver oestrogen directly into the bloodstream at steadier, more consistent levels. Multiple studies and clinical guidelines now specifically recommend transdermal delivery for women with migraines, rather than oral formulations.
Stabilising oestrogen levels can actually reduce migraine frequency for many women
When transdermal HRT successfully smooths out oestrogen fluctuations, many women report a meaningful reduction in migraine days per month. Observational studies of women with menstrual migraine — attacks linked to the pre-menstrual oestrogen drop — show particular benefit from steady oestrogen supplementation. For women whose migraines are clearly hormonally driven, this stabilisation effect can be genuinely transformative.
The progestogen component of HRT can also influence migraine pattern
Progestogens are not a neutral add-on for women who still have a uterus — some synthetic progestogens, particularly older norethisterone-based types, have been associated with worsening headache and mood symptoms. Micronised progesterone (body-identical progesterone) appears better tolerated neurologically and is often the preferred choice for migraine-prone women. Switching progestogen type is a legitimate and under-used clinical lever if migraines worsen on HRT.
Cyclical versus continuous HRT regimens produce different migraine profiles
Cyclical HRT — where progestogen is taken for roughly 12–14 days per month — can recreate a monthly hormone withdrawal that mirrors the menstrual cycle and triggers cyclical migraines in susceptible women. Continuous combined HRT, taken every day without breaks, eliminates this withdrawal phase and is often better tolerated by women with progestogen-sensitive migraines. Women who notice migraines clustering in the progestogen phase of a cyclical regimen should raise this pattern with their prescribing clinician.
Migraine with aura and combined oral contraceptives carry a stroke risk — but HRT is a different calculation
Women with migraine with aura are advised against combined hormonal contraceptives containing oestrogen because of a small but real increased stroke risk — and this warning understandably makes many women cautious about all hormone therapy. However, HRT uses much lower doses of oestrogen than contraceptive pills, and transdermal HRT does not appear to carry the same thrombotic risk profile. Current guidance does not class migraine with aura as a contraindication to transdermal HRT, though the conversation with a clinician familiar with both migraine and menopause medicine is essential.
Dose matters: too high an oestrogen dose can also worsen migraines
While low or fluctuating oestrogen drives most perimenopausal migraines, supraphysiological levels — doses that push oestrogen higher than the body is accustomed to — can paradoxically trigger attacks in some women. This is most likely to occur when starting HRT or after a dose increase, and it typically settles once the body adjusts. Titrating to the lowest effective dose rather than assuming more is better is particularly relevant for migraine-prone women.
Keeping a migraine and hormone diary is the single most useful practical tool
Because HRT's effect on migraines is so individual, tracking attack frequency, severity, timing in relation to HRT doses, and cycle phase provides the clearest evidence for whether a regimen is helping or hurting. A simple diary kept for two to three months before and after starting or changing HRT can reveal patterns that neither the woman nor her clinician could otherwise detect. Apps designed for migraine tracking can make this easier, and the data makes clinical conversations far more productive.
HRT and migraine-specific treatments can be used together safely
Starting or adjusting HRT does not require stopping existing migraine medications — triptans, CGRP-targeted therapies, and preventive treatments are all compatible with HRT. In practice, some women find their triptan use drops significantly once oestrogen levels stabilise on HRT, while others continue to need their usual acute treatments alongside it. The goal is not to replace one approach with the other, but to address both the hormonal fluctuation and the migraine mechanism simultaneously if needed.
Want to go deeper?
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.